StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Down 6.6 %
Shares of XXII opened at $0.10 on Monday. 22nd Century Group has a 52-week low of $0.09 and a 52-week high of $9.88. The stock has a 50 day moving average price of $0.33 and a 200 day moving average price of $1.07. The company has a market capitalization of $840,808.80, a price-to-earnings ratio of 0.00 and a beta of 1.39.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.36) EPS for the quarter. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%. The company had revenue of $7.95 million during the quarter.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Financial Services Stocks Investing
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Trading Halts Explained
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What is Forex and How Does it Work?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.